关注
Bhargav T Nallapu
Bhargav T Nallapu
其他姓名BT Nallapu, Bhargav Nallapu, Bhargav Teja Nallapu
Albert Einstein College of Medicine
在 einsteinmed.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Dynamics of reward based decision making: A computational study
BT Nallapu, NP Rougier
Artificial Neural Networks and Machine Learning–ICANN 2016: 25th …, 2016
52016
Interacting roles of lateral and medial Orbitofrontal cortex in decision-making and learning: A system-level computational model
BT Nallapu, F Alexandre
bioRxiv, 867515, 2019
32019
Plasma biomarkers as predictors of progression to dementia in individuals with mild cognitive impairment
BT Nallapu, KK Petersen, RB Lipton, C Davatzikos, A Ezzati
Journal of Alzheimer's Disease, 1-16, 2024
22024
Association of alcohol consumption with cognition in older population: The A4 Study
BT Nallapu, KK Petersen, RB Lipton, E Grober, RA Sperling, A Ezzati
Journal of Alzheimer's Disease 93 (4), 1381-1393, 2023
22023
The art of scaling up: a computational account on action selection in basal ganglia
BT Nallapu, BR Surampudi, NP Rougier
2017 International Joint Conference on Neural Networks (IJCNN), 52-58, 2017
12017
Factors affecting reward based decision making: a computational study
BT Nallapu, BR Surampudi, NP Rougier
3rd International Conference on Cognition, Brain and Computation, 2015
12015
A weakly-supervised, MRI-guided clustering of cognitive decline: A post-hoc analysis of the EXPEDITION-3 clinical trial
BT Nallapu, KK Petersen, I Demirsoy, RB Lipton, C Davatzikos, L Rabin, ...
Alzheimer's Association International Conference, 2024
2024
CSF levels of proinflammatory and anti-inflammatory cytokines as predictors of cognitive decline across Alzheimer’s disease spectrum (N4. 004)
K Petersen, B Nallapu, R Lipton, A Ezzati
Neurology 102 (17_supplement_1), 5461, 2024
2024
Impact of sex and ApoE4 on the longitudinal association of plasma ptau‐181 and NFL with cognitive decline in non‐demented older adults
BT Nallapu, KK Petersen, RB Lipton, A Ezzati
Alzheimer's & Dementia 19, e080559, 2023
2023
Predicting of β‐amyloid Positivity Using Integer‐based Risk Scores with Blood‐based Biomarkers
KK Petersen, BT Nallapu, E Grober, RB Lipton, C Davatzikos, A Ezzati
Alzheimer's & Dementia 19, e078046, 2023
2023
Predictive Value of CSF Inflammatory Biomarkers in Alzheimer’s disease
KK Petersen, BT Nallapu, E Grober, RB Lipton, A Ezzati
Alzheimer's & Dementia 19, e078093, 2023
2023
Predicting cognitive decline in short‐term as a viable method to improve recruitment in clinical trials of Alzheimer’s Disease
BT Nallapu, KK Petersen, RB Lipton, A Ezzati
Alzheimer's & Dementia 19, e072288, 2023
2023
Developing Integer‐based Risk Scores for Predicting the Risk of Incident Cognitive Impairment in Cognitively Normal Older Adults
KK Petersen, BT Nallapu, E Grober, RB Lipton, JC Morris, JJ Hassenstab, ...
Alzheimer's & Dementia 19, e078092, 2023
2023
Using Predictive Models to Reduce Heterogeneity in Alzheimer’s Disease Clinical Trials (S26. 005)
A Ezzati, K Petersen, B Nallapu, R Lipton
Neurology 100 (17_supplement_2), 3447, 2023
2023
MRI‐guided Clustering of Alzheimer’s Disease patients: A post‐hoc analysis of Phase 3 Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
KK Petersen, RB Lipton, E Grober, BT Nallapu, A Ezzati
Alzheimer's & Dementia 18, e063313, 2022
2022
Association of Cognition with Alcohol Consumption in Cognitively Unimpaired Older Adults: Results from the A4 study
BT Nallapu, KK Petersen, RB Lipton, E Grober, A Ezzati
Alzheimer's & Dementia 18, e067226, 2022
2022
Targeting the Correct Population for Trials: A Post‐hoc Analysis of Trial of Solanezumab for Mild Dementia Due to Alzheimer’s disease.
A Ezzati, KK Petersen, BT Nallapu, C Davatzikos, DA Wolk, L Rabin, ...
Alzheimer's & Dementia 18, e065995, 2022
2022
Assessing Risk of Incident Cognitive Impairment Using Stages of Objective Memory Impairment (SOMI) and Cerebrospinal Fluid
KK Petersen, E Grober, RB Lipton, BT Nallapu, A Ezzati
Alzheimer's & Dementia 18, e067266, 2022
2022
Comparison of Plasma‐based Biomarkers and Cognitive Assessments in predicting progression of MCI to Dementia
BT Nallapu, KK Petersen, RB Lipton, DJ Harvey, A Ezzati
Alzheimer's & Dementia 18, e067464, 2022
2022
Neurosmart, une histoire de cerveau et de passionné· e· s de science
F Alexandre, D Chiron, IC Kaadoud, M Courbin-Coulaud, S Dagar, ...
Inria, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20